Supernus Pharmaceuticals (SUPN) Asset Writedowns and Impairment (2023 - 2026)
Supernus Pharmaceuticals (SUPN) reported Asset Writedowns and Impairment of $54.92 million for Q2 2026.
Powered by 
Analysis
Supernus Pharmaceuticals (SUPN) Asset Writedowns and Impairment (2023 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Supernus Pharmaceuticals' Asset Writedowns and Impairment came in at $57.19 million, up 670.3% year-over-year; for FY2025, it was $1.93 million, down 78.4% from FY2024.
- Asset Writedowns and Impairment has a three-year compound annual growth rate of -43.1% (FY2022 to FY2025).
- By year, Asset Writedowns and Impairment came in at $8.9 million in FY2024 (-55.9%), $20.19 million in FY2023 (+93.3%) and $10.44 million in FY2022.
- The Q2 2026 figure ranks as the highest quarterly Asset Writedowns and Impairment in data going back to Q4 2023.
- Year over year, Asset Writedowns and Impairment gained in 1 of the last four quarters, with growth averaging 12.8%.
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.82 million (Q1 2026), $698,000 (Q4 2025) and -$239,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Supernus Pharmaceuticals | 2.47 Bn | 1.12 Bn | 185.39 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 54.92 Mn |
| Mar 31, 2026 | 1.82 Mn |
| Dec 31, 2025 | 698,000.00 |
| Sep 30, 2025 | -239,000.00 |
| Mar 31, 2025 | 547,000.00 |
| Dec 31, 2024 | 6.91 Mn |
| Sep 30, 2024 | -29,000.00 |
| Jun 30, 2024 | 1.29 Mn |
| Mar 31, 2024 | 730,000.00 |
| Dec 31, 2023 | 20.20 Mn |
API Access
Supernus Pharmaceuticals Asset Writedowns and Impairment API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=SUPN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-writedowns-and-impairment", "ticker": "SUPN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=SUPN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();